Annual Financials for Protagonist Therapeutics Inc.
Assets
Fiscal year is January-December. All values USD millions. |
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
Cash & Short Term Investments |
128.86M | 133.03M | 305.82M | 326.9M | 237.36M | |
Cash Only |
82.24M | 33.02M | 117.37M | 123.67M | 125.74M | |
Short-Term Investments |
- | - | - | - | - | |
Cash & Short Term Investments Growth |
- | 3.23% | 129.89% | 6.89% | -27.39% | |
Cash & ST Investments / Total Assets |
92.39% | 85.17% | 93.95% | 94.02% | 95.74% | |
Total Accounts Receivable |
6.51M | 7.5M | 3.82M | 5.33M | 52,000 | |
Accounts Receivables, Net |
- | 6.76M | 2.43M | 1.57M | 10,000 | |
Accounts Receivables, Gross |
- | 6.76M | 2.43M | 1.57M | 10,000 | |
Bad Debt/Doubtful Accounts |
- | - | - | - | - | |
Other Receivables |
- | 744,000 | 1.4M | - | - | |
Accounts Receivable Growth |
- | 15.17% | -49.05% | 39.57% | -99.02% | |
Accounts Receivable Turnover |
4.75 | 0.03 | 7.49 | 5.13 | 511.17 | |
Inventories |
- | - | - | - | - | |
Finished Goods |
- | - | - | - | - | |
Work in Progress |
- | - | - | - | - | |
Raw Materials |
- | - | - | - | - | |
Progress Payments & Other |
- | - | - | - | - | |
Other Current Assets |
2.13M | 4.79M | 5.97M | 8.5M | 5.67M | |
Miscellaneous Current Assets |
- | - | - | - | - | |
Total Current Assets |
137.5M | 145.31M | 315.61M | 340.74M | 243.08M | |
|
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
Net Property, Plant & Equipment |
861,000 | 7.72M | 6.41M | 6.73M | 4.63M | |
Property, Plant & Equipment - Gross |
2.94M | 10.36M | 9.89M | 10.99M | 9.88M | |
Buildings |
- | - | - | - | - | |
Land & Improvements |
- | - | - | - | - | |
Computer Software and Equipment |
- | - | - | - | - | |
Other Property, Plant & Equipment |
405,000 | 1.38M | 1.4M | 1.9M | 2M | |
Accumulated Depreciation |
2.08M | 2.64M | 3.47M | 4.26M | 5.25M | |
Total Investments and Advances |
450,000 | 450,000 | 2.45M | 225,000 | 225,000 | |
Other Long-Term Investments |
450,000 | 450,000 | 2.45M | 225,000 | 225,000 | |
Long-Term Note Receivable |
- | - | - | - | - | |
Intangible Assets |
- | - | - | - | - | |
Net Goodwill |
- | - | - | - | - | |
Net Other Intangibles |
- | - | - | - | - | |
Other Assets |
- | - | - | - | - | |
Tangible Other Assets |
- | - | - | - | - | |
Total Assets |
139.47M | 156.19M | 325.51M | 347.7M | 247.93M | |
Assets - Total - Growth |
- | 11.98% | 108.41% | 6.82% | -28.69% | |
Liabilities & Shareholders' Equity
|
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
ST Debt & Current Portion LT Debt |
- | 1.26M | 1.46M | 2.2M | 2.52M | |
Short Term Debt |
- | 1.26M | 1.46M | - | - | |
Current Portion of Long Term Debt |
- | - | - | - | - | |
Accounts Payable |
5.71M | 4.05M | 5.81M | 2.5M | 3.71M | |
Accounts Payable Growth |
- | -29.05% | 43.31% | -56.97% | 48.42% | |
Income Tax Payable |
- | - | - | - | - | |
Other Current Liabilities |
20.45M | 30.1M | 32.98M | 39.32M | 24.96M | |
Dividends Payable |
- | - | - | - | - | |
Accrued Payroll |
2.73M | 4.64M | 6.41M | 7.13M | 4.97M | |
Miscellaneous Current Liabilities |
17.72M | 25.46M | 26.56M | 32.19M | 19.99M | |
Total Current Liabilities |
26.16M | 35.41M | 40.24M | 44.02M | 31.18M | |
Long-Term Debt |
- | 15.76M | 4.5M | 3.66M | 1.14M | |
Long-Term Debt excl. Capitalized Leases |
- | 9.79M | - | - | - | |
Non-Convertible Debt |
- | 9.79M | - | - | - | |
Convertible Debt |
- | - | - | - | - | |
Capitalized Lease Obligations |
- | - | - | - | - | |
Provision for Risks & Charges |
- | - | - | - | - | |
Deferred Taxes |
(658,000) | (1.43M) | - | - | - | |
Deferred Taxes - Credit |
- | 1.27M | 1.04M | - | - | |
Deferred Taxes - Debit |
658,000 | 2.7M | 1.04M | - | - | |
Other Liabilities |
799,000 | 23.79M | 121,000 | - | - | |
Other Liabilities (excl. Deferred Income) |
799,000 | - | 121,000 | - | - | |
Deferred Income |
- | 23.79M | - | - | - | |
Total Liabilities |
26.96M | 76.22M | 45.9M | 47.67M | 32.32M | |
Non-Equity Reserves |
- | - | - | - | - | |
Total Liabilities / Total Assets |
19.33% | 48.80% | 14.10% | 13.71% | 13.04% | |
Preferred Stock (Carrying Value) |
- | - | - | - | - | |
Redeemable Preferred Stock |
- | - | - | - | - | |
Non-Redeemable Preferred Stock |
- | - | - | - | - | |
Common Equity (Total) |
112.52M | 79.96M | 279.61M | 300.02M | 215.61M | |
Common Stock Par/Carry Value |
- | - | - | - | - | |
Retained Earnings |
(140.47M) | (217.66M) | (283.81M) | (409.36M) | (536.76M) | |
ESOP Debt Guarantee |
- | - | - | - | - | |
Cumulative Translation Adjustment/Unrealized For. Exch. Gain |
- | - | - | - | - | |
Unrealized Gain/Loss Marketable Securities |
- | - | - | - | - | |
Revaluation Reserves |
- | - | - | - | - | |
Treasury Stock |
- | - | - | - | - | |
Common Equity / Total Assets |
80.67% | 51.20% | 85.90% | 86.29% | 86.96% | |
Total Shareholders' Equity |
112.52M | 79.96M | 279.61M | 300.02M | 215.61M | |
Total Shareholders' Equity / Total Assets |
80.67% | 51.20% | 85.90% | 86.29% | 86.96% | |
Accumulated Minority Interest |
- | - | - | - | - | |
Total Equity |
112.52M | 79.96M | 279.61M | 300.02M | 215.61M | |
Liabilities & Shareholders' Equity |
139.47M | 156.19M | 325.51M | 347.7M | 247.93M | |